Almac Diagnostics Licenses GeneGo's MetaCore

Dec 27, 2006

NEW YORK (GenomeWeb News) - GeneGo said last week that Almac Diagnostics, a division of Almac Group, has licensed its MetaCore data-mining platform.

Almac Diagnostics will use MetaCore to help develop its microarray-based products diagnosing and treating cancer.

The company will also use the platform in its genomic services division.

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.